Repurposing of eluxadoline as a SARS-CoV-2 main protease inhibitor: E-Pharmacophore based virtual screening, molecular docking, MM-GBSA calculations, and molecular dynamics simulations studies.

Saved in:
Bibliographic Details
Title: Repurposing of eluxadoline as a SARS-CoV-2 main protease inhibitor: E-Pharmacophore based virtual screening, molecular docking, MM-GBSA calculations, and molecular dynamics simulations studies.
Authors: Mohamed, Magdi A.1 maelhussein@ju.edu.sa, Alanazi, Alaa F.2, Alanazi, Waad A.2, Elsaman, Tilal1, Mohamed, Malik S.3, Eltayib, Eyman M.3
Source: Journal of Applied Pharmaceutical Science. Jan2025, Vol. 15 Issue 1, p102-110. 9p.
Database: Academic Search Ultimate
Description
ISSN:22313354
DOI:10.7324/JAPS.2024.204792